ADE (Incidence %) | Antineoplastons | Lashford et al., 2002, Temozolomide [21] | Warren et al., 2012, 06‑Benzylguanine and Temozolomide [23] | ||
Gr. 3 | Gr. 4 | Gr. 3/Gr. 4 | Gr. 3 | Gr. 4 | |
Hypokalemia | 2.3 | ||||
Hypernatremia | 4.6 | 13.9 | |||
Fatigue | 1 | ||||
Somnolence | 2.3 | 2.3 | |||
Thrombocytopenia | 7 | 17 | 2 | ||
Neutropenia | 12 | 32 | |||
Leukopenia | 5 | 15 | 10 | ||
Lymphopenia | 24 | 2 | |||
Anemia | 7 | ||||
Vomiting | 2 | 2 | |||
Anorexia | <1 | ||||
Infection | 5 | ||||
Sepsis | 2 | ||||
Pneumonia | 2 | ||||
Fever | |||||
Neuropathy | <1 | ||||
Seizures | <1 | ||||
Headache | 2 | ||||
Pain | <1 |